• The Strategic Action on Health, managed by the Carlos III Health Institute (ISCIII), is the main tool to finance biomedical and health research in Spain. 

The Council of Ministers approved on Tuesday the agreement authorising the 2023 call for grants from the Strategic Action on Health (AES), managed by the Carlos III Health Institute (ISCIII), which has a budget of about 144.3 million euros with national funds, 28% more than in 2018. This amount comes from the General State Budgets, thus consolidating the increasing and progressive financing established by the new Law on Science, Technology and Innovation.

The Minister of Science and Innovation, Diana Morant, has highlighted that the Government of Spain has placed health research as a priority to tackle diseases such as cancer. Morant pointed out that this new call promotes R&D&I on health in Spain, facilitating the development of research careers and offering opportunities for our researchers to continue developing biomedical science of the highest quality. 
The AES, which is published every year, is the main tool for financing biomedical and health research in Spain. This programme awards grants for the implementation of contracts and research projects to promote the development of R+D+I in health in our country and the careers of the research community in this field.  

The actions of the AES are aimed at protecting the health of citizens through R+D+I and respond to the priorities in population health in the preventive, diagnostic, curative, rehabilitative and palliative aspects of diseases.
 
What's New at AES 2023 
 
The AES 2023 continues to promote the creation of permanent jobs linked to post-doctoral programmes of excellence, an initiative that began with the Miguel Servet contracts and that this year is extended to the Juan Rodés contracts. Another highlight is the incorporation of the R3 certificate, created in the new Law of Science, Technology and Innovation.

In addition, the AES is adding new lines of health research this year related to the study of the social impact of health policies, digital innovation and chronicity, among others.

These research lines are in addition to those already established by the State Scientific and Technical Research and Innovation Plan 2021-2023, including research in vulnerable populations, the reduction of health inequalities, the study of the social determinants of health, advanced therapies and infectious diseases.

In addition to the AES 2023, the calls corresponding to the European funds of the Recovery, Transformation and Resilience Plan within the framework of the PERTE for Cutting-edge Health.